US-based National Surveillance for Fidaxomicin Susceptibility of Clostridioides Difficile (Formerly Clostridium) Associated Diarrheal Isolates From 2013-2016

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00391-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium Difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Fidaxomicin for Clostridium Difficile-Associated Diarrhoea

Clinical Drug Investigation
MedicinePharmacology
2012English

Fidaxomicin Use and Clinical Outcomes for Clostridium Difficile–Associated Diarrhea

Infectious Diseases in Clinical Practice
Infectious DiseasesMicrobiology
2015English

Clostridioides Difficile in National Food Surveillance, Slovenia, 2015 to 2017

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2020English

Germination of Spores of Clostridium Difficile Strains, Including Isolates From a Hospital Outbreak of Clostridium Difficile-Associated Disease (CDAD)

Microbiology
Microbiology
2009English

Molecular Characterisation of Czech Clostridium Difficile Isolates Collected in 2013–2015

International Journal of Medical Microbiology
MedicineInfectious DiseasesMicrobiology
2016English

Recurrent Clostridium Difficile Colitis in Elderly: The Role of Fidaxomicin

Clinical Management Issues
MedicineAccountingManagementBusiness
2014English

Fidaxomicin in the Treatment of Colitis Due to Clostridium Difficile: Preliminary Results

Clinical Management Issues
MedicineAccountingManagementBusiness
2014English

In Vitro Susceptibility of Clostridium Difficile Clinical Isolates From a Multi-Institutional Outbreak in Southern Quebec, Canada

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy